Céline Verheust, PhD

GSK, Wavre, Belgium
Wavre, Vlaams-Brabant, Belgium

Disclosure(s): GSK: Salary as GSK employee, with stock options included, Stocks/Bonds (Public Company)

Presentation(s):

• 574 - Early Post-Marketing Safety Surveillance for the Respiratory Syncytial Virus Prefusion F Protein Vaccine (RSVPreF3 OA)

  Saturday, October 19, 2024
  2:39 PM – 2:59 PM US PT